Cargando…
Calreticulin down-regulation inhibits the cell growth, invasion and cell cycle progression of human hepatocellular carcinoma cells
BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most frequent cancers in the world. Calreticulin(CRT) is aberrantly overexpressed in many human cancer cells. The function of CRT in HCC cells remains unclear. We attempted to investigate the effects and the underlying mechanisms of CRT down-r...
Autores principales: | Feng, Ruo, Ye, Jianwen, Zhou, Chuang, Qi, Lei, Fu, Zhe, Yan, Bing, Liang, Zhiwei, Li, Renfeng, Zhai, Wenlong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549864/ https://www.ncbi.nlm.nih.gov/pubmed/26307067 http://dx.doi.org/10.1186/s13000-015-0382-1 |
Ejemplares similares
-
Calreticulin: a potential diagnostic and therapeutic biomarker in gallbladder cancer
por: Ye, Jianwen, et al.
Publicado: (2021) -
Critical role for the long non-coding RNA AFAP1-AS1 in the proliferation and metastasis of hepatocellular carcinoma
por: Lu, Xu, et al.
Publicado: (2016) -
Metformin suppresses hypoxia-induced migration via the HIF-1α/VEGF pathway in gallbladder cancer in vitro and in vivo
por: Ye, Jianwen, et al.
Publicado: (2019) -
Calreticulin increases growth and progression of natural killer/T-cell lymphoma
por: Zheng, Yan, et al.
Publicado: (2020) -
Lenvatinib induces anticancer activity in gallbladder cancer by targeting AKT
por: Ye, Jianwen, et al.
Publicado: (2021)